In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK B receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics

By Idanpaan-Heikkila J.J.   Perrot S.   Guilbaud G.   Kayser V.  

European Journal of Pharmacology, Vol. 325, Iss. 2, 1997-05 ,pp. : 155-164

Elsevier

Access to resources Recommend Favorite

A selective CCK B receptor antagonist potentiates -, but not -opioid receptor-mediated antinociception in the formalin test

By Noble F.   Blommaert A.   Fournie-Zaluski M.-C.   Roques B.P.  

European Journal of Pharmacology, Vol. 273, Iss. 1, 1995-01 ,pp. : 145-151

Elsevier

Access to resources Recommend Favorite

Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK B receptor antagonist

By Makovec F.   Revel L.   Letari O.   Mennuni L.   Impicciatore M.  

European Journal of Pharmacology, Vol. 369, Iss. 1, 1999-03 ,pp. : 81-90

Elsevier

Access to resources Recommend Favorite

His 381 of the rat CCK B receptor is essential for CCK B versus CCK A receptor antagonist selectivity

By Jagerschmidt A.   Guillaume-Rousselet N.   Vikland M.-L.   Goudreau N.   Maigret B.   Roques B.-P.  

European Journal of Pharmacology, Vol. 296, Iss. 1, 1996-01 ,pp. : 97-106

Elsevier

Access to resources Recommend Favorite

Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCK B receptor antagonist

By Valverde O.   Blommaert A.G.S.   Fournie-Zaluski M.-C.   Roques B.P.   Maldonado R.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 79-93

Elsevier

Access to resources Recommend Favorite